JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 38 No. 6 977-979
© 1997 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baroli, A.
Right arrow Articles by Inglese, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baroli, A.
Right arrow Articles by Inglese, E.

Feasibility of a Rapid Method to Evaluate Platelet Survival Time

Alberto Baroli, Marco Brambilla, Giuseppina Antonini>, Laura Ciardi, Giorgio Bordin, Gianni Cardani, Marco Rudoni, Gianmauro Sacchetti and Eugenio Inglese

Departments of Nuclear Medicine and Medicine, Azienda Ospedaliera "Maggiore della Carità," Novara, Italy

Correspondence: For correspondence or reprints contact: Alberto Baroli, MD, Department of Nuclear Medicine, Azienda Ospedaliera "Maggiore della Carità," Corso Mazzini 18-28100 NOVARA, Italy.

ABSTRACT

The purpose of this study was to evaluate the feasibility of a shorter method of performing platelet kinetic studies with respect to the conventional 8-9-day approach. Methods: We studied 41 patients (28 women, 13 men; mean age 52 yr) with primary idiopathic trombocytopenic purpura (IIP) (n = 20), secondary IIP (n = 9), HCV associated thrombocytopenia (n = 9), splenectomy (n = 1) and hairy-cell leukemia (n = 1). The patients were in a steady-state of platelet turnover. Initial platelet counts ranged from 19 to 302 x 109/liter (mean value = 83). Platelet survival times (PST) were measured from the blood radioactivity disappearance curve of 111In-oxine-labeled autologus platelets following the recommendations of the International Committee for Standardization in Haematology: blood samples were taken at 30 min and 2 and 4 hr and thereafter daily for 7 days. PST was calculated by the weighted mean method and ranged from 18 to 219 hr (mean value = 98). PST was also calculated using only the data collected at 2,48 and 96 hr. If the radioactivity in the blood at 96 hr exceeded 10% of the 2-hr value, the additional point at 168 hr was used. Results: By using this reduced dataset, we obtained a correlation of r = 0.97 with the PST obtained from the whole dataset. In 24 patients, the difference was between ± 10 hr and exceeded 1 day in only 4. Conclusion: About 94% of the data may be recovered with only three or four blood samples and the duration may be shortened to 4 days in a significant proportion of patients (48% of ITP patients). This approach offers the advantages of increased patient throughput, compliance and reduced examination costs.

Key Words: platelet survival time • indium-111-oxine • agreement analysis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1997 by the Society of Nuclear Medicine.